Scroll below to see how CADIENT can put the right actions into your
We promote brand health in the digital ecosystem.
We drive the interactions—and transactions—that empower your brand.
We focus on your metric value—not volume.
We don’t just create your digital platform. We innovate.
We help you experience digital intuition.
We build your digital universe from the wireframes up.
We cultivate meaningful long-term relationships between your customers and your brand.
We don’t help you keep up with the latest digital marketing trends—
we help you set them.
When no one can find your digital footprint, we step up the search.
We’re passionate aboutwhat we do (and it shows).
A consumer has over 379,000 brand experiences in a year.
31% of doctors make Rx decisions from smartphones.
90% of patients want online access to health information and education.
Research at 3M Corporation concluded that we process visuals 60,000 times faster than text.
90% of the world’s total data has been created just within the past 2 years.
We’re more than digital communicators.We’re digital innovators.
Stephen Wray oversees worldwide business operations for Cadient Group, including strategic and financial direction, corporate and product development, and investor and industry relations. With over 25 years of experience in healthcare communications, his strategic expertise spans a wide range of therapeutic areas and customer segments within the pharmaceutical and biopharmaceutical sectors.
Prior to joining Cadient, Steve was North American Regional President and CEO, US, for Ogilvy Healthworld. His experience covers professional and consumer marketing, strategic brand development, professional and patient education, and relationship marketing on a global scale. He served as Vice President of Marketing Communications for Wyeth (now Pfizer) and has held roles in sales, sales training, corporate development, franchise and brand development, customer alliances, and corporate communications. Steve has been a recipient of the Ernst and Young Entrepreneur of the Year Award, and has been recognized for excellence in leadership as part of the PharmaVOICE 100 Most Inspirational People in the Life Sciences Industry (2012). Steve was also listed among the SmartCEO100 for the Philadelphia region (2011).
A native Californian with degrees in Marketing and Advertising from Fresno State University, Steve resides with his family in the Philadelphia region.
As the Chief Innovation Officer at Cadient Group, William Reese leads the innovation team to identify strategic opportunities within the healthcare space to drive deeper relationships with professionals, consumers, and payers. Will brings more than 10 years of healthcare industry experience providing marketing strategy, program management, information architecture, and technical consulting for major pharmaceutical clients including Pfizer, AstraZeneca, and Johnson & Johnson. He has developed award-winning campaigns for numerous category-leading brands, and he has extensive product launch and professional marketing knowledge.
Prior to joining Cadient Group in 2002, Will developed interactive solutions for Lippincott Williams & Wilkins’ electronic medical publishing group. There, he managed both the project development and quality assurance of interactive CME programs, online journals, and hospital education intranets.
Will holds a Bachelor's degree in Biology with a dual minor in Economics and Chemistry from the State University of New York at Cortland.
As Chief Customer Officer, Chris Mycek oversees Cadient Group’s customer development process, aligning the agency’s unique range of digital services with existing and emerging client needs. Recognized as a top-tier strategic marketer, his multi-channel marketing repertoire includes more than 20 years of experience in supporting the development of digital marketing for multi-national organizations in the life science, consumer packaged goods, consumer electronics, financial services, and food industries.
Having worked on both the client and agency sides, Chris is recognized as an expert in his field. His experience in developing category-leading brands within the pharmaceutical, biotech, and consumer healthcare categories has paralleled his ability to integrate new channels and technologies into the marketing mix. When added to the depth of commercial innovation expertise that the Cadient Group has formed across its teams, this role represents an important bridge to help both existing and future clients achieve unprecedented success.
Chris, along with his team, partners with Cadient Group's commercial innovation and customer engagement divisions to help life science companies optimize the marketing performance of their brands and marketing initiatives.
Prior to joining Cadient Group, Chris leveraged digital channels for some of the largest brands in the world, expanding healthcare practices with Johnson & Johnson and within Digitas Health, imc2, RealAge, and Revolution Health. Most recently, he served as Executive Vice President at Influence Interactive, a full-service digital agency based in Philadelphia.
Chris holds a Bachelor of Arts in Economics from Middlebury College.
As Chief Operations Officer at Cadient Group, Charlie Walker is responsible for advancing the strategic and operational leadership of Cadient Group’s entire business network. Charlie brings more than 15 years of experience in agency operations, client services, and technology product development and implementation to the firm. He is also responsible for overseeing the overall quality and delivery of Cadient Group’s solutions and services to clients.
Prior to joining Cadient Group, Charlie was Chief Operating Officer of G2 Interactive, a digital marketing agency, and WPP company, where he oversaw agency operations, client services, and shared service teams across three office locations. His experience also includes technology and consumer medical device product development at companies such as Johnson & Johnson and GHR Systems—one of the nation’s leading providers of lending technology services in the financial services industry.
Charlie earned a Bachelor’s degree from the United States Military Academy at West Point and a Master of Business Administration degree from Rutgers University.
As VP of Commercial Innovation, Gabrielle leads Cadient's efforts to help life science companies optimize the performance of their brands and marketing operations. Leveraging digital technology and other tools for fostering innovation, she and her team create business strategies that deliver results-oriented planning, best-in-class customer insights, and productive new approaches to global marketing and brand commercialization.
Gabrielle joined Cadient from AstraZeneca, where she built a 18-year management career spanning a broad range of responsibilities. Most recently, she served as Global Director of Commercial Innovation, leading enterprise-wide digital marketing initiatives in Japan. Prior to that, she was brand director for managed markets in the U.S., guiding major brands through key life cycle events and creating a large cross-functional team to address issues such as access and reimbursement.
From 2005 to 2010, Gabrielle acquired substantial global innovation experience, working as global brand manager for AstraZeneca UK, then as marketing director for AstraZeneca Japan. She began her pharmaceutical career in product management, working also as a district sales manager before moving into brand management.
Gabrielle holds both a Bachelor of Science in Agricultural Business Management and a Bachelor of Science in Animal Science from North Carolina State University.
As Cadient Group’s Vice President of Finance, Mark Bogas is responsible for supporting the strategic direction of the company and tactically driving the strategic shifts in the business model. Mark has over 20 years of cumulative financial management and accounting experience, including 8 years in the banking industry and nearly a decade in the accounting and finance recruiting industry.
Mark has been instrumental in establishing Cadient Group’s financial infrastructure to support the company for rapid growth in all dimensions. He has been involved with managing the overall business plan and with establishing and maintaining financial policies and procedures. He oversees accounting, budgets, financial reporting, treasury, tax, insurance, legal, and Investor/Board relations.
Prior to joining Cadient Group, Mark held several titles at Liberty Savings Bank, served as controller at Arbill Glove & Safety Products and the SolomanEdwardsGroup, and helped lead the initial public offering of Acsys Resources, Inc. Mark received his Bachelor of Science degree in Accounting from Temple University.
As the Chief Technology Officer for Cadient, Bryan Hill is the architect of the agency’s range of digital solutions and leader of Cadient’s Global Technologies organization. He oversees a passionate team of solution architects, developers, and quality engineers delivering innovative solutions in Web, mobile, and social. Bryan has nearly twenty years of leadership experience and expertise in multiple technical areas including software development, data management, and IT consulting. In his 11 years at Cadient Group, Bryan’s primary responsibilities have been focused on growing a global digital production operation, driving technical innovation, developing digital solution strategies, and ensuring the quality delivery of Cadient's interactive healthcare offerings. He also serves on the Board of Directors for Saband Software Technologies, a software product R&D subsidiary of Cadient Group.
Prior to joining Cadient Group at its founding in 2002, Bryan led the development of Web- and desktop-based enterprise strategy management software at ActiveStrategy. Bryan’s background also includes time as a digital practice lead with IT consultancy IQGroup in Philadelphia, where his teams utilized emerging Web technologies to deliver custom solutions for clients such as American Express, Global Crossing, and the Republican National Convention 2000.
Bryan began his career in Philadelphia at Farm Journal, Inc. in 1993, where he led the development of many data-driven solutions as well as the publisher’s migration to the Web.
As the Creative Director of Copy for Cadient, Stacey drives the creative content development and execution for an ever-evolving array of agency projects, while also managing and mentoring a team of copywriters, editorial managers, proofreaders, and freelance writers. With nearly 20 years of solid copywriting and creative leadership experience—and a diverse therapeutic background—Stacey has led the creative development of a variety of domestic and international brands from initial launch throughout the entire creative campaign life cycle. Her professional repertoire includes nearly every therapeutic category—including cardiovascular disease, dermatology, oncology, ophthalmology, diabetes, vaccines, men’s and women’s health, medical devices, and mental health. She has also written about rare diseases, bleeding disorders, skin care, infant nutrition, respiratory disease, hospice care, wound care, and pain management. In addition to traditional and digital healthcare, her experience also includes consumer advertising, broadcast communications, and direct mail. She has had the opportunity to write for some of today’s most well-known brands, including Tylenol®, Johnson & Johnson®, Aveeno®, Oral B®, Nabisco®, and M&M Mars®. She has also written for some of the most recognized pharma companies, including Pfizer, Astra Zeneca, Wyeth, Sanofi-Aventis, and Bristol-Meyers Squibb.
Prior to joining Cadient, Stacey ran her own creative consulting group, providing creative direction and copywriting assistance to clients across the country, including Saatchi & Saatchi, Euro RSCG, Medical Broadcasting Company (now Digitas), Inventive Health, GSW, Knight Marketing, and the Thomas J Paul Company. An Honors graduate from Temple University, Stacey received her degree in Journalism with a focus in advertising and marketing. She resides with her family in Bucks County.
As the Creative Director of Design, James draws upon years of consumer and pharmaceutical advertising experience to serve as a champion for creativity with the Cadient Creative Services department. Specializing in concept, ad campaigns, and brand personality development, James brings outstanding brand and pharmaceutical knowledge to his role as Creative Director at Cadient Group.
James developed his category and drug launch experience with work on products including REYATAZ®, Synvisc®, Mirena®, Vasotec®, ZOCOR®, and Zemaira®, and with clients that have included Merck, Bristol-Myers Squibb, Wyeth Labs, Berlex, Roche, CSL Behring, GlaxoSmithKline, and Acclarent.
Before joining Cadient, James developed his creative expertise at several agencies, including Young & Rubicam, Bozell, Klemtner Advertising, Vicom/FCB, 30 West Advertising, The Hal Lewis Group, The Navicor Group, and Roska Healthcare.
As the Associate Creative Director of design, Erik sets the overall creative direction for Cadient’s multi-channel marketing initiatives, while managing a team of art directors, media designers, production artists and freelancers. Erik’s responsibilities include branding, identity, messaging, and conceptual ideation. Erik has worked on numerous pharmaceutical and healthcare-related accounts for both professional and consumer audiences. Healthcare areas of experience include hemophilia, pain management, oncology, asthma, ADHD, devices, professional portals, and consumer products. Before arriving at Cadient, Erik worked closely with Wyeth Pharmaceuticals on their Hemophilia Village project.
Erik is an award-winning designer with over 20 years of professional experience in Web, print, video, and interactive design. Erik has an extensive background in all genres of design, including entertainment, corporate, educational, and pharmaceutical creative. Erik has been a thriving and influential member of Cadient Group for the past 10 years.
As the Executive Director, Organizational & Systems Development of Cadient Group, Chad manages areas as diverse as human capital, total compensation, information systems, and facilities. By implementing enterprise-wide innovations to meet evolving talent and infrastructure needs, he enables Cadient Group to deliver best-in-class digital marketing solutions for our clients.
A global cross-functional team leader, Chad is backed by 17 years in accounting, finance, human capital, and technology. He serves on the Board of Directors of Cadient Group’s subsidiary in India, Saband Software Technologies. His extensive technology background comprises ERP, CRM, and PSA operational systems, Cloud solutions/computing, collaborative systems, business intelligence, mobile, and infrastructure design.
Chad is a cum laude graduate of Cabrini College, with a Bachelor of Science degree in Accounting. He is active in numerous professional organizations, including the Society of Human Resource Management, the Microsoft® Dynamics GP User Group, Philly Area SharePoint User Group, and the Philadelphia CFO Alliance, an exclusive community for finance leaders and decision makers.
Mr. Holloway oversees the continual evolution of precision-driven strategies, programs, and partnerships. With nearly 20 years of marketing and advertising experience in healthcare businesses, he has worked on a wide range of Rx and OTC drugs. Mr. Holloway has led interactive strategy development and implementation for brands in a number of therapeutic areas, including CNS, women’s health, GI, and oncology.
Prior to joining Cadient Group, Mr. Holloway was the Vice President/Account Group Supervisor of Sweeney & Partners (now the Bozell Healthcare Group), where he provided marketing strategy and account management for the agency’s clientele. Mr. Holloway also worked for Vicks/Procter & Gamble as an associate marketing manager in brand management.
As a strong advocate in his community, Mr. Holloway is the treasurer of the Board for Exodus To Excellence, an educational program in West Philadelphia. He holds a degree in chemical engineering from the Georgia Institute of Technology and an MBA from the Wharton School of Business at the University of Pennsylvania.
As the Senior Manager of New Media, Tim is responsible for creative production and development of rich media solutions involving video, audio, animation, and other multimedia technologies and formats. Currently, he oversees all new media and RUX projects and staff; serves as a creative lead on all video and audio productions; provides conception and architecture for RUX; leads internal and external teams within video, audio, Flash, games, animation, and 3D. He continues brainstorming and concepting new ideas and solutions to clients' needs.
A part of Cadient Group since its inception, Tim spent the last decade growing the digital and new media offerings at Cadient Group. He became manager of digital media and created standards and best practices for large format displays. He also standardized Flash design and development at Cadient Group, and explored new ways of engaging convention audience members with digital signage, attract loops, games, and highly engaging Rich User Experiences. In addition, Tim created Cadient Group’s New Media Department, where he oversees all Rich User Experiences (RUX) and Rich User Applications (RUA) creative and development.
Tim has over 14 years of experience in the audio and video industry, including the following: post-production sound and video editing; video production; video special effects; video and audio Web integration; compression and encoding; motion graphics and animation. He also worked in the post-production field for Howard Schwartz Recording, NYC (HSRNY).
As the Associate Creative Director for Design, Jason oversees a team of art directors, media designers and freelancers to ensure the highest level of creativity for various Cadient projects. Jason began his career as a Flash designer/developer where he developed his passion and expertise for interactive design. Jason is part of the award-winning team with 10 years of creative experience. Jason’s interactive world began within the eMarketing group at Mellon Financial in Pittsburgh, Pennsylvania. After tackling the financial industry for a few years, Jason moved east to the Philadelphia area where he became an Interactive Art Director for reputable agencies such as Refinery Inc. and Digitas Health before joining Cadient in 2009 and becoming an Associate Creative Director. He has experience working on brands such as: CRESTOR®, Symbicort®, Pulmicort®, GARDASIL®, CINRYZE®, and many more.
Jason has a Bachelor of Science degree in Multimedia Design as well as Information Systems & Management.
Cadient Group's Board of Directors
helps provide guidance to the agency's
management team. We invite you
to review their professional experience.
John Martinson is the managing partner of the Edison Venture Fund, Cadient Group’s sole investor. He joined Cadient Group’s Board of Directors in 2006, and he has served as director and advisor to 12 companies focused primarily on the pharmaceutical industry. Currently, he is lead investor of Cambridgesoft, Health Market Science, Octagon Research Solutions, Sentrx, and Skila.
With 30 years of venture capital experience, Mr. Martinson has organized 150 equity financings. He has led multiple investments in customer relationship management, education, human resources, finance, engineering, and other business software. Under his watch, high-return investments have included Axent, Best Software, Dendrite, Marcam, Mathsoft, and POMS.
In 1986 he established the Edison Venture Fund, which has financed more companies in New Jersey, Pennsylvania, Maryland, and Virginia than any other private equity firm. In all, Edison has invested in 6 partnerships totaling $650 million. Edison specializes in application software companies with $5 million to $20 million in revenue.
Mr. Martinson earned a BS from the USAF Academy, an MS from Purdue University, and an MBA from Southern Illinois University. Mr. Martinson is past Chairman of the National Venture Capital Association, the Mid-Atlantic Capital Alliance, and the New Jersey Technology Council.
Chairman of the Board, Cadient Group
Christopher French is a managing director at Petsky Prunier LLC, a leading investment bank serving the marketing, media, technology, and service industries, including businesses focused on digital advertising, digital media, eCommerce, marketing technology, software, information, marketing services and agencies, and consultancies. Mr. French leads Petsky Prunier’s life sciences practice.
Prior to joining Petsky Prunier, Mr. French was co-head of Winterberry Group, Petsky Prunier’s strategy consulting affiliate. Previously, Mr. French served as Chief Executive Officer of Cadient Group and as Senior Vice President of global solutions marketing and corporate development at Dendrite International, a provider of software, information, and service solutions to the global life sciences industry. Mr. French began his professional career as a merger and acquisition associate at Skadden, Arps, Slate, Meagher & Flom, a leading global law firm with headquarters in New York City.
Mr. French is a graduate of the Fordham University School of Law and received a BS in economics from the Wharton School at the University of Pennsylvania. He is also the former chairman of the Board of Trustees for the Epiphany School Foundation in New York City.
Jim Walker has been working in the pharmaceutical industry for 17 years. He is founder of Octagon Research Solutions, Inc. Prior to founding Octagon, he worked as the senior manager of worldwide regulatory affairs for the Schering–Plough Corporation ("Schering"). While at Schering, he was responsible for clinical and pre-clinical in the antihistamine, central nervous system, and critical care therapeutic areas.
Prior to joining Schering, Mr. Walker worked across multiple therapeutic areas in the Regulatory Affairs/Clinical and Clinical Quality Assurance department at the R.W. Johnson Pharmaceutical Research Institute (PRI). Mr. Walker has extensive experience in and knowledge of all phases of clinical research and both FDA and European regulations. He is skilled at process improvement and provides insight across multiple disciplines within drug development.
Mr. Walker holds a BS in Biological Sciences from Villanova University, a Master's in Environmental Sciences from Rutgers University, and an MBA from Duke University.
Steve Zarrilli is the President and Chief Executive Officer of Safeguard Scientifics, Inc. (NYSE:SFE), a growth capital provider headquartered in Wayne, PA. Steve has built a career spanning 30 years in a combination of CFO and CEO roles in both public and private companies, including serving as the CFO of Safeguard from 2008 to 2012. Steve spent the first 11 years of his career at Deloitte in Philadelphia.
In addition to his current duties, Steve is a director for several public and private enterprises including Nutrisystem, Inc. (NASDAQ:NTRI), Cadient, Inc. and the Penn Valley Group. He is also the recent past Chairman of the Advisory Board for the Arts & Business Council of Greater Philadelphia, Vice Chairman of Ben Franklin Technology Partners of Southeastern PA, and a board member of the Greater Philadelphia Chamber of Commerce. Steve previously served on three other public company boards—US Interactive, Inc. (digital marketing) from 1999 to 2000, Progress Financial Corporation (banking/ financial services) from 2000 until its sale to Fleet Bank in 2004, and Clarient, Inc. (cancer diagnostics) from 2008 until its sale in 2010 to General Electric.
Steve is a frequent speaker on a variety of business topics including strategic management, capital markets, corporate governance and entrepreneurship. He is also a member of the Board of Trustees of La Salle University, as well as the Chairman of the Advisory Board for La Salle’s Center for Entrepreneurship. In addition, Steve serves as a member of the Advisory Board of the Center for Corporate Governance of Drexel University’s LeBow School of Business, and a member of the Advisory Board on Executive Education for the Wharton School of the University of Pennsylvania.
Steve graduated from La Salle University in Philadelphia in 1983, and completed the Advanced Management Program at the Wharton School of the University of Pennsylvania in 2010.
Stephen T. Zarrilli
President and CEO,
Safeguard Scientifics, Inc.
The employees at Cadient are agile, passionate, fearless, and sometimes,
even a little outrageous—and we’re not afraid to take risks. We love to explore new territories.
And we’re always ready for action.
We’re making headlines.
Press ReleaseDigital marketing experts provide insight on how healthcare professionals can better engage and manage patient and provider expectations KING OF PRUSSIA, PA—June 27, 2013—Digital and social communications is changing the way patients, providers and healthcare marketers communicate with one another. Today, Cadient Group, a leading interactive marketing agency, released a new white paper, “Healthy Expectations: Moving Marketing from Expectations to Action,” that explains the benefits of digital patient engagement and […]
Short form messaging dates all the way back to the earliest cave drawi...
Too often, when we are well-versed in something, we forget that others...
There are a record number of consumers tracking and monitoring health ...
For fact sheet, click here
For media questions, e-mail us
We like working with people whomake things happen.
Career Opportunities //
2520 Renaissance Blvd, Suite 100
King of Prussia, PA 19406
P // 484.351.2800
E // firstname.lastname@example.org